6.160USD-6.67%Mkt Cap: 78.55M USDP/E: —Last update: 2026-06-01
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, w…
Industry Peers
Packaged FoodsIndicators:|
Key Statistics
Company
Market Cap78.55M USD
Enterprise Value99.93M USD
Revenue (TTM)134.00K USD
Gross Profit157.00K USD
Net Income (TTM)-26.17M USD
Revenue/Share0.0130 USD
Last Price6.160 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorConsumer Defensive
IndustryPackaged Foods
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.66
PEG—
EV/EBITDA-5.09
EV/Revenue745.78
P/S625.56
P/B-4.11
EPS (TTM)-3.25
EPS (Forward)-1.79
52W Range
2.67032% of range13.50
52W High13.50 USD
52W Low2.670 USD
Profitability
Gross Margin78.50%
Oper. Margin-13740.00%
EBITDA Margin0.00%
Profit Margin-13086.50%
ROE148.78%
ROA-144.35%
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.55M USD
CapEx (TTM)39.00K USD
FCF Margin-8638.90%
FCF Yield-14.74%
Net Debt16.11M USD
Net Debt/EBITDA-0.82
Balance Sheet
Debt/Equity-1.23
Current Ratio1.94
Quick Ratio1.40
Book Value/Sh-1.5970 USD
Cash/Share0.4650 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 11, 2024
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)32.20 USD
Target Range20.00 USD – 50.00 USD
# Analysts5
Ownership
Shares Out.12.78M
Float10.43M
Insiders17.06%
Institutions20.44%
Short Interest
Short Ratio1.1d
Short % Float13.85%
Short % Out.10.35%
Shares Short1.32M
Short (prev mo.)876.91K
Technical
SMA 506.248 (-1.4%)
SMA 2006.490 (-5.1%)
Beta0.89
S&P 52W Chg27.94%
Avg Vol (30d)930.95K
Avg Vol (10d)141.17K
Technical Indicators
RSI (14)50.5
MACD0.0878
MACD Signal0.1512
MACD Hist.-0.0634
BB Upper7.696 USD
BB Middle6.809 USD
BB Lower5.922 USD
BB Width26.07%
ATR (14)0.5861 USD
Vol Ratio (20d)0.03x